Literature DB >> 11770697

Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjects.

D A Gentile1, W J Doyle, P Fireman, D P Skoner.   

Abstract

BACKGROUND: The economic impact and medical complication rate of viral upper respiratory infections are well documented, but many of the physiologic, inflammatory, and immune responses to respiratory viruses have only recently been investigated. A previous study demonstrated differential systemic immune and inflammatory responses in allergic rhinitis (AR) and nonallergic rhinitis (NAR) subjects during experimental infection with rhinovirus-39.
OBJECTIVE: The purpose of this study was to compare selected systemic immune and inflammatory responses to experimental influenza A virus (FLU) challenge in seronegative AR and NAR subjects.
METHODS: Peripheral blood was obtained at baseline (study day 0) and 3, 6, 18, and 31 days after intranasal FLU challenge and assayed for leukocyte histamine release, serum immunoglobulins, and plasma histamine.
RESULTS: All subjects were infected, as manifested by viral shedding in nasal secretions and/or seroconversion. FLU infection induced decreases in spontaneous leukocyte histamine release and increases in anti-immunoglobulin E-induced leukocyte histamine release, which were evident at least 1 month after infection, but caused no significant changes in serum immunoglobulins or plasma histamine. There were no differences between AR and NAR subjects for any of the study parameters.
CONCLUSIONS: The results show that intranasal challenge with FLU induces changes in leukocyte histamine release, but not other systemic immune and inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770697     DOI: 10.1016/S1081-1206(10)62263-6

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  9 in total

1.  Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

Authors:  Matthew J Memoli; Lindsay Czajkowski; Susan Reed; Rani Athota; Tyler Bristol; Kathleen Proudfoot; Sarah Fargis; Matthew Stein; Rebecca L Dunfee; Pamela A Shaw; Richard T Davey; Jeffery K Taubenberger
Journal:  Clin Infect Dis       Date:  2014-11-20       Impact factor: 9.079

Review 2.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

3.  Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses.

Authors:  Debby van Riel; Michael A den Bakker; Lonneke M E Leijten; Salin Chutinimitkul; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

Review 4.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

5.  Alternaria alternata challenge at the nasal mucosa results in eosinophilic inflammation and increased susceptibility to influenza virus infection.

Authors:  M Ma; J L Redes; C M Percopo; K M Druey; H F Rosenberg
Journal:  Clin Exp Allergy       Date:  2018-04-15       Impact factor: 5.018

Review 6.  Small-volume detection: platform developments for clinically-relevant applications.

Authors:  Wei-Hsuan Sung; Yu-Ting Tsao; Ching-Ju Shen; Chia-Ying Tsai; Chao-Min Cheng
Journal:  J Nanobiotechnology       Date:  2021-04-21       Impact factor: 10.435

Review 7.  Mast cells and influenza a virus: association with allergic responses and beyond.

Authors:  Amy C Graham; Rachel M Temple; Joshua J Obar
Journal:  Front Immunol       Date:  2015-05-18       Impact factor: 7.561

8.  The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology.

Authors:  Amy Caryn Sherman; Aneesh Mehta; Neal W Dickert; Evan J Anderson; Nadine Rouphael
Journal:  Front Cell Infect Microbiol       Date:  2019-04-17       Impact factor: 5.293

9.  Assessing mathematical models of influenza infections using features of the immune response.

Authors:  Hana M Dobrovolny; Micaela B Reddy; Mohamed A Kamal; Craig R Rayner; Catherine A A Beauchemin
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.